BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 24470869)

  • 1. The Impact of Immune Response on HTLV-I in HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
    Rafatpanah H; Farid Hosseini R; Pourseyed SH
    Iran J Basic Med Sci; 2013 Mar; 16(3):235-41. PubMed ID: 24470869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenetics and the Pathological Mechanisms of Human T-Cell Leukemia VirusType 1- (HTLV-1-)Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
    Saito M
    Interdiscip Perspect Infect Dis; 2010; 2010():478461. PubMed ID: 20169122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients.
    Casseb J; de Oliveira AC; Vergara MP; Montanheiro P; Bonasser F; Meilman Ferreira C; Smid J; Duarte AJ
    J Med Virol; 2008 Mar; 80(3):392-8. PubMed ID: 18205234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunopathogenesis of HTLV-1-assoaciated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Fuzii HT; da Silva Dias GA; de Barros RJ; Falcão LF; Quaresma JA
    Life Sci; 2014 May; 104(1-2):9-14. PubMed ID: 24704970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell receptor repertoire analysis in HTLV-1-associated diseases.
    Clauze A; Enose-Akahata Y; Jacobson S
    Front Immunol; 2022; 13():984274. PubMed ID: 36189294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Nozuma S; Kubota R; Jacobson S
    J Neurovirol; 2020 Oct; 26(5):652-663. PubMed ID: 32705480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in a long-term prospective cohort study of initially asymptomatic individuals in Brazil.
    Romanelli LC; Caramelli P; Martins ML; Gonçalves DU; Proietti FA; Ribas JG; Araújo MG; Carneiro-Proietti AB
    AIDS Res Hum Retroviruses; 2013 Sep; 29(9):1199-202. PubMed ID: 23617363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mediators of central nervous system damage during the progression of human T-cell leukemia type I-associated myelopathy/tropical spastic paraparesis.
    Barmak K; Harhaj EW; Wigdahl B
    J Neurovirol; 2003 Oct; 9(5):522-9. PubMed ID: 13129766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Enose-Akahata Y; Jacobson S
    Retrovirology; 2019 Nov; 16(1):35. PubMed ID: 31783764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development.
    Espíndola OM; Oliveira LC; Ferreira PM; Leite AC; Lima MA; Andrada-Serpa MJ
    Intervirology; 2015; 58(2):106-14. PubMed ID: 25833232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human T-Lymphotropic Virus-1-Associated Myelopathy/Tropical Spastic Paraparesis Is Associated With Sexual Dysfunction in Infected Women of Reproductive Age.
    Lopes Martins AL; Rios Grassi MF; de Aquino Firmino A; Lacerda Araujo JP; Paixao TS; Galvão-Castro B; Boa-Sorte N
    Sex Med; 2018 Dec; 6(4):324-331. PubMed ID: 30181035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma.
    Giusti RM; Maloney EM; Hanchard B; Morgan OS; Steinberg SM; Wachter H; Williams E; Cranston B; Fuchs D; Manns A
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):699-704. PubMed ID: 8877061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and cofactors for human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica.
    Krämer A; Maloney EM; Morgan OS; Rodgers-Johnson P; Manns A; Murphy EL; Larsen S; Cranston B; Murphy J; Benichou J
    Am J Epidemiol; 1995 Dec; 142(11):1212-20. PubMed ID: 7485068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Saito M; Matsuzaki T; Satou Y; Yasunaga J; Saito K; Arimura K; Matsuoka M; Ohara Y
    Retrovirology; 2009 Feb; 6():19. PubMed ID: 19228429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infective dermatitis has similar immunological features to human T lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis.
    Nascimento MC; Primo J; Bittencourt A; Siqueira I; de Fátima Oliveira M; Meyer R; Schriefer A; Santos SB; Carvalho EM
    Clin Exp Immunol; 2009 Jun; 156(3):455-62. PubMed ID: 19438598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible implication of NFKB1A and NKG2D genes in susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian patients infected with HTLV-1.
    Talledo M; López G; Huyghe JR; Verdonck K; González E; Clark D; Vanham G; Gotuzzo E; Van Camp G; Van Laer L
    J Med Virol; 2012 Feb; 84(2):319-26. PubMed ID: 22170554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tax secretion from peripheral blood mononuclear cells and Tax detection in plasma of patients with human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis and asymptomatic carriers.
    Medina F; Quintremil S; Alberti C; Godoy F; Pando ME; Bustamante A; Barriga A; Cartier L; Puente J; Tanaka Y; Valenzuela MA; Ramírez E
    J Med Virol; 2016 Mar; 88(3):521-31. PubMed ID: 26241614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression changes of cytotoxicity and apoptosis genes in HTLV-1-associated myelopathy/tropical spastic paraparesis patients from the perspective of system virology.
    Ghazvini K; Youssefi M; Keikha M
    Access Microbiol; 2020; 2(3):acmi000088. PubMed ID: 32974568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of T Regulatory Lymphocytes Transcription Factors in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) Patients.
    Ghezeldasht SA; Sadeghian H; Azarpazhooh MR; Shamsian SAA; Rafatpanah H; Mahmoodi M; Rezaee SA
    Appl Biochem Biotechnol; 2017 Aug; 182(4):1403-1414. PubMed ID: 28101786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.